Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
H3 histone pseudogene 44 (H3P44) is a presumed, noncoding genomic sequence annotated as a pseudogene in histone family H3. Pseudogenes such as H3P44 do not encode a functional histone protein, and no evidence supports their translation or direct impact on cellular processes. Canonical histone H3 variants, including H3.1, H3.2, H3.3, H3.Y, and H3T, regulate chromatin accessibility, gene expression, and cellular differentiation through incorporation into nucleosomes and various post-translational modifications[1][6][4][5][2]. There is no evidence to support a role for H3P44 as a therapeutic target, receptor, enzyme, or biomarker. The aliases "H3P44," "p55," and "H3.8" are not widely recognized in the context of human histone nomenclature and may represent annotation errors[5][2].
None.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on H3 histone pseudogene 44 (H3P44).